In addition, circAGO2 facilitated its enrichment and activation on the 3’-untranslated region of target genes by interacting with human antigen R (HuR) protein, reducing argonaute 2 (AGO2) binding and repressing the silencing of AGO2/miRNA-mediated genes related to cancer progression [87]. Here, ELAVL1 is linked to cancer.